14 completed, 9 unknown, 8 recruiting, 3 terminated. 37 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 37 | Completed 14, Unknown 9, Recruiting 8, Terminated 3, Withdrawn 2, Active not recruiting 1 |
Follow Tongue Diseases: new trials by email Literature Review of Tongue Diseases trials Research Report on Tongue Diseases
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Surgeon-performed Ultrasound for Real-time Guidance In Oral Cancer Surgeries - A Multicenter Randomized Controlled Trial Ultrasound imaging, Standard Treatment - Tongue Cancer, Oral Cancer | Not applicable | Recruiting | Tobias Todsen | 150 | 2025-09-15 | 2026-05-13 |
| High-Resolution PET-CT Imaging for Surgical Margin Visualization Intra-op PET/CT Specimen Scanner - Cancer, Solid Malignant Tumors | Not applicable | Recruiting | Vanderbilt-Ingram Cancer Center | 50 | 2025-09-03 | 2026-05-08 |
| Normative Ranges of Lingual Strength and Endurance and the Impact of the IOPI Lingual Strength Trainer on Quantitative Functional Outcomes and Patient-Reported Outcomes After Partial Glossectomy or Hemiglossectomy for Oral Tongue Cancer, An Unblinded: Randomized Pilot Study Iowa Oral Performance Instrument (IOPI) - Tongue Cancer | Not applicable | Recruiting | Memorial Sloan Kettering Cancer Center | 60 | 2025-08-07 | 2026-06-30 |
| Assessment of the Effect of Tumor Thickness and Site on Level IV Cervical Lymph Nodes in Squamous Cell Carcinoma of the Tongue and Floor of the Mouth: A Case Series Study removal of primary tumor, neck dissection - Tongue Neoplasms | Not applicable | Unknown | Cairo University | 20 | 2024-04-01 | 2024-05-29 |
| Surgical Margin Assessment by 3D Ultrasound 3D ultrasound - Tongue Cancer, Squamous Cell Carcinoma | Not applicable | Unknown | Copenhagen University Hospital, Rigshospitalet | 7 | 2023-01-01 | 2023-02-23 |
| Alpha Radiation Emitters Device for the Treatment of Cutaneous, Mucosal and Superficial Soft Tissue Neoplasia (DaRT) Device: Radiation: Diffusing Alpha Radiation Emitters Therapy (DaRT) - Skin Cancer, Mucosal Neoplasm of Oral Cavity | Not applicable | Terminated | Alpha Tau Medical LTD. | 2 | 2021-07-08 | 2025-12-08 |
| Clinical Study Evaluating the Proper Surgical Safety Margin for Early Stage Oral Tongue Cancers 1.5 cm surgical safety margin for cT1-2N0 oral tongue cancers, 1.0 cm surgical safety margin for cT1-2N0 oral tongue cancers - Tongue Cancer, Tongue Cancer TNM Staging Primary Tumor (T) T1 | Not applicable | Terminated | Samsung Medical Center | 125 | 2021-01-18 | 2025-05-18 |
| Retreatment With Intratumoral Diffusing Alpha Radiation Emitters Radiation: Diffusing Alpha Radiation Emitters Therapy (DaRT) - Skin Cancer, Mucosal Neoplasm of Oral Cavity | Not applicable | Completed | Alpha Tau Medical LTD. | 2 | 2020-12-22 | 2025-12-02 |
| Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia Radiation: Diffusing Alpha Radiation Emitters Therapy (DaRT) - Skin Cancer, Mucosal Neoplasm of Oral Cavity | Not applicable | Recruiting | Alpha Tau Medical LTD. | 56 | 2020-12-22 | 2026-06-16 |
| Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia. Radiation: Diffusing Alpha Radiation Emitters Therapy (DaRT) - Skin Cancer, Mucosal Neoplasm of Oral Cavity | Not applicable | Recruiting | Alpha Tau Medical LTD. | 30 | 2020-10-21 | 2025-12-02 |
| Ultrasound in Tongue Cancer- a Help to Decide Depth of Invasion and to Improve the Surgical Margin Ultrasound - Tongue Cancer, Floor of Mouth Squamous Cell Carcinoma | Not applicable | Completed | Region Örebro County | 42 | 2019-05-28 | 2021-12-27 |
| Alpha Radiation Emitters Device for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia (DaRT) Radiation: Diffusing Alpha Radiation Emitters Therapy (DaRT) - Skin Cancer, Mucosal Neoplasm of Oral Cavity | Not applicable | Active not recruiting | Alpha Tau Medical LTD. | 30 | 2018-12-31 | 2026-04-06 |
| Adjuvant Radiotherapy in Early Stage Oral Cancers Post-operative adjuvant radiotherapy - Cancer of Mouth, Cancer of the Tongue | Not applicable | Completed | Tata Memorial Hospital | 392 | 2018-08-02 | 2026-01-16 |
| Patient's Pretreatment Expectations About Post-Lyme Symptoms Antibiotics (preferentially oral doxycycline 100 mg bid) - Erythema Migrans | Not applicable | Recruiting | University Medical Centre Ljubljana | 200 | 2018-06-01 | 2026-04-29 |
| Quality of Life in Patients Treated for Tongue and/or Jaw Neoplasia Before and After Speech Therapy Speech-language guidance, Speech therapy exercises for swallowing, Speech therapy exercises for speech - Tongue Cancer, Jaw Cancer | Not applicable | Completed | Hospital de Clinicas de Porto Alegre | 30 | 2018-03-01 | 2019-10-15 |
| Prosthesis Guided Speech Rehabilitation of T1/T2 Cancers of the Tongue Palatal Augmentation Prosthesis (PAP), Articulation Therapy - Tongue Neoplasms, Tongue Cancer | Not applicable | Recruiting | University of Michigan | 40 | 2018-01-02 | 2026-05-08 |
| Inflammatory Mediators in Erythema Migrans Doxycycline 7 days, Doxycycline 14 days - Erythema Migrans | Not applicable | Completed | University Medical Centre Ljubljana | 150 | 2017-06-01 | 2020-11-03 |
| Hypofractionated Radiation Therapy Followed by Surgery in Treating Patients With Advanced Squamous Cell Carcinoma of the Oral Cavity hypofractionated radiation therapy, intensity-modulated radiation therapy, therapeutic conventional surgery - Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage III Verrucous Carcinoma of the Oral Cavity | Not applicable | Withdrawn | Rutgers, The State University of New Jersey | 2016-08-01 | 2022-09-28 | |
| Lyme Borreliosis and Early Cutaneous Diagnostic Skin biopsies - Erythema Migrans | Not applicable | Completed | University Hospital, Strasbourg, France | 84 | 2015-08-06 | 2026-07-13 |
| Cetuximab and Radiation Therapy in Treating Patients With Stage III-IV Head and Neck Cancer cetuximab, cisplatin, external beam radiation therapy - Stage III Squamous Cell Carcinoma of the Hypopharynx, Stage III Squamous Cell Carcinoma of the Larynx | Not applicable | Terminated | Rutgers, The State University of New Jersey | 8 | 2015-03-25 | 2021-04-21 |
Showing 20 of 37. Sign in to see all of them.
Tongue Neoplasms (29) · Squamous Cell Carcinoma of Head and Neck (15) · Mouth Neoplasms (10) · Carcinoma, Squamous Cell (8) · Glossitis, Benign Migratory (8) · Head and Neck Neoplasms (8) · Lyme Disease (6) · Carcinoma, Basal Cell (5) · Lip Neoplasms (5) · Sarcoma, Kaposi (5) · Skin Neoplasms (5) · Soft Tissue Neoplasms (5) · Carcinoma, Non-Small-Cell Lung (3) · Hypopharyngeal Neoplasms (3) · Laryngeal Neoplasms (3)
Mouth Diseases (37) · Stomatognathic Diseases (37) · Neoplasms by Site (29) · Neoplasms (27) · Head and Neck Neoplasms (21) · Mouth Neoplasms (19) · Neoplasms by Histologic Type (18) · Neoplasms, Glandular and Epithelial (18) · Carcinoma (17) · Infections (11) · Carcinoma, Squamous Cell (9) · Glossitis (8) · Neoplasms, Squamous Cell (8) · Skin Diseases (8)
Doxycycline (4) · Ceftriaxone (2) · Fluorodeoxyglucose F18 (2) · Ultrasonography (2) · 1-phenyl-3,3-dimethyltriazene (1) · 5-fluoropentyl-2-methylmalonic acid (1) · Acupuncture Therapy (1) · Anesthesia, Intravenous (1) · Anti-Bacterial Agents (1) · BID protein, human (1) · Biopsy (1) · Cetuximab (1) · Cisplatin (1) · Deglutition (1) · Gefitinib (1)
University Medical Centre Ljubljana (7) · Alpha Tau Medical LTD. (5) · Ohio State University Comprehensive Cancer Center (3) · Memorial Sloan Kettering Cancer Center (2) · Rutgers, The State University of New Jersey (2) · American College of Radiology Imaging Network (1) · Cairo University (1) · Copenhagen University Hospital, Rigshospitalet (1) · East and North Hertfordshire NHS Trust (1) · Hospital de Clinicas de Porto Alegre (1) · National Cancer Institute (NCI) (1) · Personal Improvement Computer Systems (1) · Region Örebro County (1) · Roswell Park Cancer Institute (1) · Samsung Medical Center (1)
United States (13) · Slovenia (7) · Israel (4) · United Kingdom (3) · China (2) · Denmark (2) · Italy (2) · Sweden (2) · Brazil (1) · Egypt (1) · France (1) · India (1) · South Africa (1) · South Korea (1)
Franc Strle, MD (2) · Franc Strle, MD, PhD (2) · Sung Kim (2) · Amit Agrawal, MD (1) · Aron Popovtzer (1) · Aron Popovtzer, M.D (1) · Beverley de Valois, PhD LicAc (1) · Dasa Stupica, MD (1) · Dasa Stupica, MD, PhD (1) · Enver Ozer, MD (1) · Eva Ruzic-Sabljic, MD, PhD (1) · Franc Strle, MD PhD (1) · Han-Sin Jeong, MD PhD (1) · Hassan Arshad, MD (1)
PMID 30075748, PMID 21917515, PMID 22523260, PMID 29385444, PMID 30768363, PMID 31611612, PMID 36537851, PMID 37650478, PMID 39454756, PMID 42185750
P30CA072720 (2), U01CA079778 (1), U01CA080098 (1), U10CA032102 (1)